Form 4 for PRAX Praxis Precision Medicines, Inc.
Accepted 2026-06-12 17:24:09 ET · period of report 2026-06-10 · accession 0001689548-26-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 17:24 | 2026-06-10 | PRAX | DeSimone Jill | Dir | A - Grant | $0.00 | +1,371 | 2,337 | +142% | $0 |
| D | 2026-06-12 17:24 | 2026-06-10 | PRAX | DeSimone Jill | Dir | A - Grant | $0.00 | +648 | 648 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-10 | A | A | 1,371 | $0.00 | 2,337 | D | — | — | (F1) Ms. DeSimone was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-10 | A | A | 648 | $0.00 | 648 | D | $240.66 · — to 2036-06-10 | 648 Common Stock | (F2) The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. |